Ephrin receptor 3D structures
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 17: | Line 17: | ||
**[[2k9y]], [[2e8n]] - hEPHR A2 transmembrane domain – NMR<BR /> | **[[2k9y]], [[2e8n]] - hEPHR A2 transmembrane domain – NMR<BR /> | ||
**[[1mqb]], [[4p2k]], [[4pdo]], [[4trl]], [[5ek7]], [[5i9u]] - hEPHR A2 kinase domain<BR /> | **[[1mqb]], [[4p2k]], [[4pdo]], [[4trl]], [[5ek7]], [[5i9u]] - hEPHR A2 kinase domain<BR /> | ||
| + | **[[7kja]] - hEPHR A2 kinase+SAM domains<br /> | ||
| + | **[[7kjb]], [[7kjc]] - hEPHR A2 kinase+SAM domains (mutant)<br /> | ||
*''Ephrin A2 receptor binary complex''<br /> | *''Ephrin A2 receptor binary complex''<br /> | ||
| Line 25: | Line 27: | ||
**[[6njz]], [[6nk0]], [[6nk1]], [[6nk2]], [[6nkp]], [[6b9l]] - hEPHR A2 LBD + peptide<br /> | **[[6njz]], [[6nk0]], [[6nk1]], [[6nk2]], [[6nkp]], [[6b9l]] - hEPHR A2 LBD + peptide<br /> | ||
**[[6rw2]] - hEPHR A2 LBD + bicycle toxin<br /> | **[[6rw2]] - hEPHR A2 LBD + bicycle toxin<br /> | ||
| + | **[[7b7n]], [[7cze]], [[7czf]] - hEPHR A2 LBD + herpesvirus glycoproteins<br /> | ||
**[[2kso]] - hEPHR A2 SAM fragment residues 945-969 + SHIP2<br /> | **[[2kso]] - hEPHR A2 SAM fragment residues 945-969 + SHIP2<br /> | ||
**[[5nz9]] - hEPHR A2 SAM fragment - NMR<br /> | **[[5nz9]] - hEPHR A2 SAM fragment - NMR<br /> | ||
**[[6f7m]], [[6f7n]] - hEPHR A2 SAM fragment (mutant) - NMR<br /> | **[[6f7m]], [[6f7n]] - hEPHR A2 SAM fragment (mutant) - NMR<br /> | ||
| - | **[[5i9v]], [[5i9w]], [[5njz]], [[5nk0]], [[5nk1]], [[5nk2]], [[5nk3]], [[5nk4]], [[5nk5]], [[5nk6]], [[5nk7]], [[5nk8]], [[5nk9]], [[5nka]], [[5nkb]], [[5nkc]], [[5nkd]], [[5nke]], [[5nkf]], [[5nkg]], [[5nkh]], [[5nki]], [[6hes]], [[6het]], [[6heu]], [[6hev]], [[6hew]], [[6hex]], [[6hey]], [[6q7b]], [[6q7c]], [[6q7d]], [[6q7e]], [[6q7f]], [[6q7g]] - hEPHR A2 kinase domain + inhibitor<br /> | + | **[[5i9v]], [[5i9w]], [[5njz]], [[5nk0]], [[5nk1]], [[5nk2]], [[5nk3]], [[5nk4]], [[5nk5]], [[5nk6]], [[5nk7]], [[5nk8]], [[5nk9]], [[5nka]], [[5nkb]], [[5nkc]], [[5nkd]], [[5nke]], [[5nkf]], [[5nkg]], [[5nkh]], [[5nki]], [[6hes]], [[6het]], [[6heu]], [[6hev]], [[6hew]], [[6hex]], [[6hey]], [[6q7b]], [[6q7c]], [[6q7d]], [[6q7e]], [[6q7f]], [[6q7g]], [[8bin]], [[8bio]], [[8bk0]] - hEPHR A2 kinase domain + inhibitor<br /> |
**[[6fnf]], [[6fng]], [[6fnh]] – hEPHR A2 kinase domain + pyrimidine derivative<br /> | **[[6fnf]], [[6fng]], [[6fnh]] – hEPHR A2 kinase domain + pyrimidine derivative<br /> | ||
**[[5i9x]], [[5i9y]], [[5i9z]], [[5ia0]], [[5ia1]], [[5ia2]], [[5ia3]], [[5ia4]], [[5ia5]] - hEPHR A2 kinase domain + kinase drug<br /> | **[[5i9x]], [[5i9y]], [[5i9z]], [[5ia0]], [[5ia1]], [[5ia2]], [[5ia3]], [[5ia4]], [[5ia5]] - hEPHR A2 kinase domain + kinase drug<br /> | ||
| Line 47: | Line 50: | ||
**[[4bk4]], [[4m4p]] - hEPHR A4 ectodomain<br /> | **[[4bk4]], [[4m4p]] - hEPHR A4 ectodomain<br /> | ||
**[[2lw8]] - hEPHR A4 LBD – NMR<br /> | **[[2lw8]] - hEPHR A4 LBD – NMR<br /> | ||
| + | **[[7ofv]] - hEPHR A4 LBD + polypeptide inhibitor<br /> | ||
**[[6fnl]] – hEPHR A4 kinase domain<br /> | **[[6fnl]] – hEPHR A4 kinase domain<br /> | ||
**[[2hel]] – mEPHR A4 membrane and kinase domains – mouse<br /> | **[[2hel]] – mEPHR A4 membrane and kinase domains – mouse<br /> | ||
| Line 75: | Line 79: | ||
**[[3h8m]] – hEPHR A7 SAM<BR /> | **[[3h8m]] – hEPHR A7 SAM<BR /> | ||
**[[2rei]] - hEPHR A7 kinase domain<BR /> | **[[2rei]] - hEPHR A7 kinase domain<BR /> | ||
| + | **[[7eec]], [[7eed]], [[7eef]] - hEPHR A7 kinase domain (mutant) <br /> | ||
**[[3dko]] – hEPHR A7 kinase domain + inhibitor | **[[3dko]] – hEPHR A7 kinase domain + inhibitor | ||
| Line 90: | Line 95: | ||
**[[5mja]] - hEPHR B1 kinase domain + inhibitor<br /> | **[[5mja]] - hEPHR B1 kinase domain + inhibitor<br /> | ||
**[[5mjb]] - hEPHR B1 kinase domain (mutant) + inhibitor<br /> | **[[5mjb]] - hEPHR B1 kinase domain (mutant) + inhibitor<br /> | ||
| + | **[[6umw]] - hEPHR B1 kinase domain + antibiotics<br /> | ||
| + | **[[7kpl]] - hEPHR B1 172-450 <br /> | ||
| + | **[[7kpm]] - hEPHR B1 172-450 + ADP<br /> | ||
*Ephrin B2 receptor | *Ephrin B2 receptor | ||
| Line 127: | Line 135: | ||
**[[2xvd]], [[2yn8]], [[4bb4]] - hEPHR B4 kinase domain (mutant) + inhibitor<br /> | **[[2xvd]], [[2yn8]], [[4bb4]] - hEPHR B4 kinase domain (mutant) + inhibitor<br /> | ||
**[[2hle]], [[2bba]] - hEPHR B4 LBD + ephrin B2 | **[[2hle]], [[2bba]] - hEPHR B4 LBD + ephrin B2 | ||
| + | |||
| + | *Ephrin B6 receptor | ||
| + | |||
| + | **[[7k7j]] - hEPHR B6 ectodomain<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D Structures of ephrin receptors
Updated on 21-February-2023
